Expert Ratings for NeuroPace
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 5 analysts have provided their opinions on NeuroPace (NASDAQ:NPCE) stock, with 2 somewhat bullish and 3 indifferent ratings. The average price target is $9.2, representing an upside from the current price of $8.69. This target has increased by 41.54% from the previous target of $6.50. Analyst ratings are based on company data, financial statements, and insider information, and are intended to predict stock performance.
December 04, 2023 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
NeuroPace has received an updated average price target of $9.2 from analysts, indicating a bullish sentiment with a 41.54% increase from the previous target. The current stock price is $8.69.
The increase in the average price target suggests that analysts have a positive outlook on the stock, which could lead to increased investor confidence and a potential rise in the stock price in the short term. The unanimous absence of bearish ratings further supports the potential for an upward movement.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100